Lv13
40 积分 2024-09-20 加入
Structure and Plasticity of Indoleamine 2,3-Dioxygenase 1 (IDO1)
2小时前
已完结
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution
1天前
已完结
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED–H3K27me3 Inhibitors for the Treatment of Lymphoma
1天前
已完结
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies
1天前
已完结
Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2
5天前
已完结
Abstract 1697: CPI-169, a novel and potent EZH2 inhibitor, synergizes with CHOP <i>in vivo</i> and achieves complete regression in lymphoma xenograft models
5天前
已关闭
Covalent inhibitors of EZH2: Design, synthesis and evaluation
7天前
已完结
Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian Cancer
7天前
已完结
Asymmetric Hydrogenation by Relay Catalysis with FLPs and CPAs: Stereodivergent Synthesis of 3-Substituted Flavanones
24天前
已完结
Vitamin B6-Based Biomimetic Asymmetric Catalysis
24天前
已完结
皖公网安备34019202002308
